BHRS ads

We’re excited to bring you a 90-minute powerhouse session in partnership with the European Heart Rhythm Association (EHRA) at the BHRSymposium, covering genetic testing to guide clinical decisions, ablation and CIEDs in channelopathies. Last year, 100% of delegates said they would recommend the symposium and that it would improve their clinical practice.

Join arrhythmia heavyweights Drs Noel Fitzpatrick, Neil Grubb, Vinit Sawhney, Claire Martin, Boon Lim and more at BHRSymposium, with faculty from Ireland to Edinburgh to Southampton and everywhere in between! Highlights include: • Device sessions with focused updates on cardiac and lead management • Special channelopathies session with the European Heart Rhythm Association • Debates: “All centres should have >1 PFA system” and “EV-ICD has supplanted S-ICD” • Quick-fire clinical scenarios where expert panels defend their decisions against each other and the audience

Why does my patient need an MRI before primary prevention ICD? Should more patients undergo venoplasty for lead access? How long is too long for inpatient pacemaker implantation in the UK? These are just some of the pressing questions our outstanding faculty will tackle at the BHRSymposium this autumn. Expect quick-fire scenarios with a powerhouse panel, plus sessions on state-of-the-art management of channelopathies and focused updates on devices in cardiac and lead management.

The BHRSymposium programme is packed with the latest considerations in EP and pacing, exploring how it fits into our health service through challenging questions, MDT discussion and debate. Join more than 25 expert faculty members and 200 professionals from a range of disciplines, united by their expertise in managing arrhythmias.

Join two trailblazing organisations at the BHRSymposium! The European Heart Rhythm Association (EHRA) and BHRS come together for an exclusive session on the latest in channelopathy management, featuring Professors John Camm, Elijah Behr, Pier Lambiase and Drs Jonathan Behar and Katarzyna Małaczyńska-Rajpold. Highlights include: • Using Genetic Testing to Guide Clinical Decisions • Ablation in Channelopathies • CIEDs in Channelopathies …and more, all before lunchtime!

BHRSessions 2026 | 3–5 March | Holland House Hotel, Cardiff Clinical Innovation Partner Spotlight: Johnson&Johnson MedTech The Great Debate: Is There a Need for RF in the Era of PFA for AF Ablation? Join Dr Matthew Ginks and Dr Vishal Luther as they go head-to-head, exploring the future role of RF ablation in a landscape increasingly shaped by pulsed field ablation.